A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

被引:366
|
作者
Hughes, Anne E. [1 ]
Orr, Nick
Esfandiary, Hossein
Diaz-Torres, Martha
Goodship, Timothy
Chakravarthy, Usha
机构
[1] Queens Univ Belfast, Dept Med Genet, Belfast BT12 6BL, Antrim, North Ireland
[2] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[3] Queens Univ Belfast, Ctr Vis Sci & Vasc Biol, Belfast BT12 6BL, Antrim, North Ireland
关键词
D O I
10.1038/ng1890
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Age-related macular degeneration (AMD; OMIM #603075) is the most frequent cause of visual impairment in the elderly population, with severe disease affecting nearly 10% of individuals of European descent over the age of 75 years. It is a complex disease in which genetic and environmental factors contribute to susceptibility. Complement factor H (CFH) has recently been identified as a major AMD susceptibility gene, and the Y402H polymorphism has been proposed as the likely causative factor. We genotyped polymorphisms spanning the cluster of CFH and five CFH-related genes on chromosome 1q23 in 173 individuals with severe neovascular AMD and 170 elderly controls with no signs of AMD. Detailed analysis showed a common haplotype associated with decreased risk of AMD that was present on 20% of chromosomes of controls and 8% of chromosomes of individuals with AMD. We found that this haplotype carried a deletion of CFHR1 and CFHR3, and the proteins encoded by these genes were absent in serum of homozygotes. The protective effect of the deletion haplotype cannot be attributed to linkage disequilibrium with Y402H and was replicated in an independent sample.
引用
收藏
页码:1173 / 1177
页数:5
相关论文
共 50 条
  • [21] Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
    Zipfel, Peter F.
    Edey, Matthew
    Heinen, Stefan
    Jozsi, Mihaly
    Richter, Heiko
    Misselwitz, Joachim
    Hoppe, Bernd
    Routledge, Danny
    Strain, Lisa
    Hughes, Anne E.
    Goodship, Judith A.
    Licht, Christoph
    Goodship, Timothy H. J.
    Skerka, Christine
    PLOS GENETICS, 2007, 3 (03): : 387 - 392
  • [22] Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy
    Jullien, Perrine
    Laurent, Blandine
    Claisse, Guillaume
    Masson, Ingrid
    Dinic, Miriana
    Thibaudin, Damien
    Berthoux, Francois
    Alamartine, Eric
    Mariat, Christophe
    Maillard, Nicolas
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (02): : 661 - 669
  • [23] Relevance of Complement Factor H-Related 1 (CFHR1) Genotypes in Age-Related Macular Degeneration
    Martinez-Barricarte, Ruben
    Recalde, Sergio
    Fernandez-Robredo, Patricia
    Millan, Isabel
    Olavarrieta, Leticia
    Vinuela, Antonio
    Perez-Perez, Julian
    Garcia-Layana, Alfredo
    Rodriguez de Cordoba, Santiago
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (03) : 1087 - 1094
  • [24] Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
    Muench, Johannes
    Bachmann, Anette
    Grohmann, Maik
    Mayer, Christof
    Kirschfink, Michael
    Lindner, Tom H.
    Bergmann, Carsten
    Halbritter, Jan
    CLINICAL KIDNEY JOURNAL, 2017, 10 (06): : 742 - 746
  • [25] Association of Elevated C5a Levels, but Not the Presence of Anti-Cfh IgG Autoantibodies, with the Deletion of CFHR3 and CFHR1 in SLE.
    Zhao, Jian
    Kamble, Seema
    Deng, Yun
    Erika, Magdangal
    Sakurai, Daisuke
    Li, Rongqun
    Chen, Weiling
    Grossman, Jennifer M.
    Hahn, Bevra H.
    Tsao, Betty P.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S426 - S427
  • [26] Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
    Diep, Jason
    Potter, Daniela
    Mai, Jun
    Hsu, Danny
    BMC NEPHROLOGY, 2023, 24 (01)
  • [27] Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese
    Xie, Jingyuan
    Kiryluk, Krzysztof
    Li, Yifu
    Mladkova, Nikol
    Zhu, Li
    Hou, Ping
    Ren, Hong
    Wang, Weiming
    Zhang, Hong
    Chen, Nan
    Gharavi, Ali G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (10): : 3187 - 3194
  • [28] Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
    Jason Diep
    Daniela Potter
    Jun Mai
    Danny Hsu
    BMC Nephrology, 24
  • [29] Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab
    Freyer, Craig W.
    Bange, Erin M.
    Skuli, Sarah
    Hsu, Miles
    Lin, John
    Cuker, Adam
    Cohen, Adam D.
    Garfall, Alfred
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : E845 - E849
  • [30] ACUTE POSTTRANSPLANT AHUS DUE TO A HOMOZYGOUS DELETION OF CFHR1/CFHR3 WITH CFH-AUTOANTIBODIES MANAGED BY A CNI-FREE REGIMEN WITH BELATACEPT AND ECULIZUMAB
    Muench, J.
    Bachmann, A.
    Lindner, T. H.
    Halbritter, J.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 26 - 26